Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.74 |
| ▸ | PRKCG | P05129 | 5/20 | 0.74 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.74 |
| ▸ | PRKCB | P05771 | 4/20 | 0.74 |
| ▸ | PRKCH | P24723 | 4/20 | 0.74 |
| ▸ | PRKCI | P41743 | 4/20 | 0.74 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.74 |
| ▸ | PRKCQ | Q04759 | 4/20 | 0.74 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.74 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.74 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.74 |
| ▸ | USP2 | O75604 | 2/20 | 0.74 |
| ▸ | TP53 | P04637 | 2/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6844179 | 1.00 | PRKCA (0.74) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL8192421 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL892726 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL18210530 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL21578359 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL22171801 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL2127254 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL16904300 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL312634 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| SCHEMBL18627982 | 0.88 | PRKCA (0.79) | PRKCAPRKCGPRKD3PRKCBPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12037 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4732008-A1 | METHODS OF DETECTION FOR ENGINEERED CELLS | Allogene Therapeutics, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260063624-A1 | OXIDASE-BASED CHEMILUMINESCENCE ASSAY OF PHAGOCYTIC LEUKOCYTES IN WHOLE BLOOD AND BODY FLUIDS APPLICABLE TO POINT-OF-CARE (POC) DIAGNOSTIC TESTING POINT-OF-CARE (POC) MEASUREMENT OF ABSOLUTE NEUTROPHIL FUNCTION (ANF) | BINARY LLC (US) | 2026-03-05 | — | — | US | claimed |
| WO-2025213245-A1 | METHODS AND COMPOSITIONS FOR THE TUNABLE DIFFERENTIATION AND PRODUCTION OF SINGLE POSITIVE CD4+ AND CD8+ T CELLS AND CELLS DERIVED FROM SAME | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-10-16 | — | — | WO | claimed |
| EP-3990900-B1 | OXIDASE-BASED CHEMILUMINESCENCE ASSAY OF NEUTROPHIL LEUKOCYTES IN WHOLE BLOOD APPLICABLE TO POINT-OF-CARE (POC) MEASUREMENT OF ABSOLUTE NEUTROPHIL FUNCTION (ANF) | BINARY LLC (US) | 2025-08-20 | — | — | EP | claimed |
| EP-4244622-B1 | METHOD FOR DIAGNOSING AND MONITORING SEPSIS | SEROXO LTD (GB) | 2025-08-13 | — | — | EP | claimed |
| WO-2025125356-A1 | A METHOD FOR DETERMINING THE ACTIVITY OF A DRUG OR DRUG CANDIDATE UNDER CONDITIONS OF MICROGRAVITY | KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE (SA) | 2025-06-19 | — | — | WO | claimed |
| US-20250172544-A1 | METHOD FOR DIAGNOSING AND MONITORING SEPSIS | SEROXO LIMITED (GB) | 2025-05-29 | — | — | US | claimed |
| US-20250163377-A1 | THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH | NIMMUNE BIOPHARMA, INC. (US) | 2025-05-22 | — | — | US | claimed |
| WO-2025072571-A1 | CELL CULTURE WITHIN MICROFLUIDIC STRUCTURES | Cellanome, Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| US-20250044283-A1 | MONITORING COVID-19 PROGRESSION AND TREATMENT | SEROXO LIMITED (GB) | 2025-02-06 | — | — | US | claimed |
| US-4882424-A | IMMUNOLOGY | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1989-11-21 | — | — | US | claimed |
| US-4877742-A | MEASURING INFLUENCE OF EARLY PREGNANCY FACTOR IN BLOOD OR URINE BY MEASURING ITS EFFECT ON FORMATION OF ELECTRONICALLY EXCITED STATES | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-10-31 | — | — | US | claimed |
| EP-0328552-A1 | THROMBIN DERIVED POLYPEPTIDES, COMPOSITIONS AND METHODS FOR USE. | UNIV TEXAS (US) | 1989-08-23 | — | — | EP | claimed |
| US-4777241-A | ISOLATED FROM TUMOR CELL CULTURES | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1988-10-11 | — | — | US | claimed |
| EP-0282160-A2 | A method of obtaining a retrovirus-containing fraction from retrovirus-containing cells | THE UNIVERSITY OF LIVERPOOL (GB) | 1988-09-14 | — | — | EP | claimed |
| WO-1988003151-A2 | THROMBIN DERIVED POLYPEPTIDES; COMPOSITIONS AND METHODS FOR USE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1988-05-05 | — | — | WO | claimed |
| EP-0230781-A2 | Lymphotoxin gene, method for its production, and lymphotoxin | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-08-05 | — | — | EP | claimed |
| EP-0149751-A2 | Proteinaceous substance showing antitumorous action and method for its manufacture | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1985-07-31 | — | — | EP | claimed |
| US-4411992-A | CULTURES, CANCER, MITOSIS | IMMUNEX CORPORATION (US) | 1983-10-25 | — | — | US | claimed |
| US-4401756-A | FROM MALIGNANT CELL CULTURE | IMMUNEX CORPORATION (US) | 1983-08-30 | — | — | US | claimed |